May 03, 2020
BioMarin Extends Gene Therapy Leadership with DiNAQOR in a Preclinical Collaboration and License Agreement to Develop Gene Therapies for Rare Genetic Cardiomyopathies
Apr 28, 2020
Gracell Reports Data of First-in-human Clinical Trial for Universal TruUCAR(TM) GC027 in Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia at the AACR Virtual Annual Meeting
Apr 28, 2020
Denovo Biopharma To Acquire Tocagen's Entire Replicating Gene Therapy Platform and Related Assets
Apr 27, 2020
CARsgen Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for Fully Human Anti-BCMA CAR-T Cells (CT053) for the Treatment of Multiple Myeloma
Apr 23, 2020
FUJIFILM Diosynth Biotechnologies Enters Strategic Partnership With OXGENE(TM) To Address Supply Bottlenecks In Gene Therapy Development And Manufacturing
Apr 22, 2020
Novartis Kymriah® receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma
Apr 17, 2020
CAR T-Cell Therapy for Non-Hodgkin's Lymphoma | US & EU Market Sizes from 2017 to 2030, Details of Marketed & Emerging Therapies Kymriah (Novartis) & KTE-X19 (Gilead Sciences)
Apr 13, 2020
Gracell to Present the First-in-human, Universal TruUCAR(TM) GC027 Therapy for Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia at the AACR Annual Meeting
Apr 06, 2020
Prime Therapeutics launches PreserveRx(SM) gene therapy financial protection
Apr 03, 2020
Gracell Announces China MNPA Acceptance of Investigational New Drug Application for GC007g Cell Therapy for CD19 Positive Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Apr 01, 2020
Locana Expands Leadership Team with Appointment of Micah Mackison, as Chief Business Officer
Mar 31, 2020
REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAV® Technology Platform for the Treatment of Rare Metabolic Disorder
Mar 25, 2020
Global Viral Vector and Plasmid DNA Manufacturing Market to Surpass US$ 2,205.6 Million by 2027 - CMI
Mar 24, 2020
Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies
Mar 12, 2020
Global CNS Drug Delivery Market Insights & Outlook, 2017-2028 - Cell & Gene Therapies Will Play an Important Role in the Treatment of Neurological Disorders in the Future
Mar 10, 2020
PhRMA Report Shows Nearly 400 Cell and Gene Therapies in Development to Target a Broad Range of Diseases
Mar 10, 2020
Advanced Therapy Medicinal Products Market Size Worth $9.6 Billion by 2026: Grand View Research, Inc.
Mar 09, 2020
GEMoaB Announces First Patient Apheresed in a Phase IA Study With Lead Product Candidate From Rapidly Switchable Universal CAR-T Platform (UniCAR) in CD123 Positive Relapsed/Refractory Acute Leukemias
Mar 03, 2020
BioIVT Now Provides Same-day Delivery of Fresh Leukopaks and Immune Cell Products in the UK and Overnight to EU Locations
Mar 03, 2020
Avectas and CCRM Announce Collaboration to Accelerate Development of Novel Technology for Cell Therapies